Search

Clinical WG1. Establishing a standard for tinnitus: patient assessment and characterisation

Rilana Cima and Haúla Haider introduce an ambitious pan-European collaboration that seeks to establish guidelines for achieving best clinical practice for managing, assessing and treating patients with different tinnitus profiles. Tinnitus heterogeneity is the major reason for inconsistent results in...

The lessons in setting up a community ENT service in the NHS

Sudeb Mandal, a GP with special interest in ENT, talks about the novel approach taken in the community to deliver ENT services in Kent in the UK. The Kent Community ENT service was born with the vision to bring together...

Listening differences in autistic individuals

In this article Erin Schafer, Lauren Mathews and Andrea Dunn outline the common auditory issues that autistic individuals face in comparison with their neurotypical peers and highlight the need to move beyond the traditional audiologic test battery when working with...

Insight into an Indian-trained ENT specialist working in the UK

With international fellowships becoming more commonplace for gaining subspecialty experience, the authors describe the pros and cons of a UK fellowship and summarise the differences they have noticed in training and clinical practice between India and the UK. Otorhinolaryngology, or...

Deaf identity is not cookie cutter shaped: a CI user in a hearing world

Sam Burgess tells us what deaf identity means to her as a service manager in a busy healthcare library, with a cochlear Implant. To begin with, I have been deaf since birth due to congenital rubella. I have not known...

Platinum-based chemotherapy, tinnitus and hearing loss

Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.

Developing medical devices for children: opportunities and challenges

The development of medical devices for infants and children lags significantly behind the development of devices for adults. While in the United States the Food and Drug Administration (FDA) has set up incentives for developing child age-specific pharmaceuticals, there is...

Timing of surgery in chronic rhinosinusitis: does it matter?

While many patients with chronic rhinosinusitis respond to medical treatment, some do not. The next step for these patients is surgery, but how soon should this be offered? Sooner rather than later seems to be the answer, as Claire Hopkins...